Last updated on November 2017

This clinical study will measure the effectiveness of a new adjunctive treatment for people with type 1 diabetes.


Brief description of study

This clinical study will measure the effectiveness of a new adjunctive treatment for people with type 1 diabetes.

Detailed Study Description

The purpose of this study is to evaluate the effectiveness of empagliflozin as a complimentary treatment to people with type 1 diabetes.

Clinical Study Identifier: TX13826

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Pacific Research Partners

Pacific Research Partners
Oakland, CA USA
  Connect »